AdultPediatricMeningococcal Vaccination Pending FDA approval for active immunization to prevent invasive meningococcal disease caused by Neisseria meningitidis serogroups A, B, C, Y, and W-135 in persons aged 10-25 yearsMeningococcal Vaccination Pending FDA approval for active immunization to prevent invasive meningococcal disease caused by Neisseria meningitidis serogroups A, B, C, Y, and W-135 in persons aged 10-25 years Mechanism of Action Pentavalent vaccine targeting meningococcal serogroups A, B, C, Y and W Conveys active immunity via stimulation of production of endogenously produced antibodies No images available for this drug. No images available for this drug.A Patient Handout is not currently available for this monograph.Print